Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID Study

BACKGROUND: The SARS-CoV-2 variant of concern, omicron, appears to be less severe than delta. We aim to quantify the differences in symptom prevalence, risk of hospital admission, and symptom duration among the vaccinated population. METHODS: In this prospective longitudinal observational study, we...

Descripción completa

Detalles Bibliográficos
Autores principales: Menni, Cristina, Valdes, Ana M, Polidori, Lorenzo, Antonelli, Michela, Penamakuri, Satya, Nogal, Ana, Louca, Panayiotis, May, Anna, Figueiredo, Jane C, Hu, Christina, Molteni, Erika, Canas, Liane, Österdahl, Marc F, Modat, Marc, Sudre, Carole H, Fox, Ben, Hammers, Alexander, Wolf, Jonathan, Capdevila, Joan, Chan, Andrew T, David, Sean P, Steves, Claire J, Ourselin, Sebastien, Spector, Tim D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8989396/
https://www.ncbi.nlm.nih.gov/pubmed/35397851
http://dx.doi.org/10.1016/S0140-6736(22)00327-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8989396/
https://www.ncbi.nlm.nih.gov/pubmed/35397851
http://dx.doi.org/10.1016/S0140-6736(22)00327-0

Ejemplares similares